White House zeroes in on dark horse candidate that could make Mike Johnson's woes worse
White House sources said Carter was under consideration for FDA commissioner, and a source said he was interested in the role.
SOURCE CHECK
TAP FOR WHYRaw Story is an established digital news outlet with named bylines, but its institutional credibility is tempered here by the article's reliance on another outlet's reporting and anonymous sources. The article does attribute its claims and identify NOTUS as the reporting source.
- Source type — An established national digital news outlet, though not a newspaper of record or major wire service.
- Transparency — The article identifies NOTUS as the source of key reporting and attributes statements to White House sources.
- Author attribution — A named author is listed.
- Source selection — Several claims rely on anonymous sources and reporting attributed to another outlet.
The brief article attributes its central claims to NOTUS and anonymous White House sources, and includes relevant context about Carter and the FDA vacancy. It offers no direct comment from Carter or the White House and little independent corroboration or detail about the selection process.
HOW WE SCORE ↗The article includes the reported case for Carter's qualifications and context for the FDA vacancy, but the central account relies on unnamed sources and does not include a response from Carter or the White House.
- Source diversity — Key information comes from White House sources relayed through NOTUS; no direct interview or response from Carter is included.
- Counterarguments presented — No opposing view or alternative account of Carter's potential selection is given.
- Opinion vs reporting — The body is presented as reporting rather than opinion.
- Loaded language — The headline's “woes worse” wording adds a negative frame, while the body is comparatively restrained.
The reporting is mostly matter-of-fact, but the headline frames the possibility as worsening Mike Johnson's difficulties. The article otherwise attributes claims and does not make a sustained partisan argument.
- Language tone — The body uses largely neutral wording and attributes claims to sources.
- Headline — The phrase “make Mike Johnson's woes worse” uses a negative frame.
- Framing — The article links Carter's possible move to Republican departures and Johnson's challenges without extended argument.
White House sources told NOTUS that former Rep. Buddy Carter is being considered to lead the FDA and that he is interested in the role. Carter’s departure from Congress comes as House Republicans face primary defeats and vacancies, which the article says could worsen Speaker Mike Johnson’s challenges.
NOTUS reported that White House sources are considering former Rep. Buddy Carter for FDA commissioner. Carter lost his 2025 Senate primary and plans to leave Congress at the end of the year. A source described him as interested in the position and cited his pharmacy experience and relationships across the administration and industry.
The article says House Speaker Mike Johnson and House Republicans have faced primary defeats, vacancies, promotions and retirements. It also reports that FDA Commissioner Marty Makary resigned in April after pressure to approve fruit-flavored vapes, which had frustrated the White House.
Community verdict
VOTING CLOSED
No good or bad look here
This story reports what happened without casting Carter in a good or bad light, so readers don’t rate it and it doesn’t count toward Carter’s record.
People in this story
SWIPE →
Senator whose seat Carter sought in the 2025 primary
House Speaker mentioned in connection with Republican departures and primary defeats
President whose administration is considering candidates for FDA commissioner
Discussion · 0
Loading comments…